Extraintestinal manifestations of inflammatory bowel disease: Do they influence treatment and outcome?

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 22

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

714

HTML

6725

Figures (1-8)

213

Sum=7652

Jun 14, 2011 (publication date) through Sep 20, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jun 14, 2011; 17(22): 2702-2707
Published online Jun 14, 2011. doi: 10.3748/wjg.v17.i22.2702

Full Size Figure Download Figure

Figure 5 Pyoderma gangrenosum before, during and after treatment with infliximab.

Citation: Veloso FT. Extraintestinal manifestations of inflammatory bowel disease: Do they influence treatment and outcome? World J Gastroenterol 2011; 17(22): 2702-2707
URL: https://www.wjgnet.com/1007-9327/full/v17/i22/2702.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i22.2702